Hess G - Search Results

1

Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.

Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ. Aronow HD, et al. Among authors: hess g. Am J Ther. 2010 Mar-Apr;17(2):167-75. doi: 10.1097/MJT.0b013e3181b442b9. Am J Ther. 2010. PMID: 19770794

2

Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.

Hess G, Sanders KN, Hill J, Liu LZ. Hess G, et al. Am J Manag Care. 2007 Jun;13 Suppl 3:S80-5. Am J Manag Care. 2007. PMID: 17596116 Free article.

3

Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits.

Hill JW, Shreay S, McGarvey N, De AP, Hess GP, Corey-Lisle PK. Hill JW, et al. Support Care Cancer. 2013 Nov;21(11):2957-65. doi: 10.1007/s00520-013-1830-7. Epub 2013 Jun 12. Support Care Cancer. 2013. PMID: 23756616

4

Effect of reimbursement changes on erythropoiesis-stimulating agent utilization and transfusions.

Hess G, Nordyke RJ, Hill J, Hulnick S. Hess G, et al. Am J Hematol. 2010 Nov;85(11):838-43. doi: 10.1002/ajh.21837. Am J Hematol. 2010. PMID: 20976794 Free article.

5

Clinical burden of illness in patients with neuroendocrine tumors.

Hess GP, Chen CC, Liu Z, Yao JC, Phan AT, Hill JW. Hess GP, et al. Pancreas. 2012 Oct;41(7):1058-62. doi: 10.1097/MPA.0b013e318249d8f7. Pancreas. 2012. PMID: 22513292

6

Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy.

Hess G, Hill J, Lau H, Dastani H, Chaudhari P. Hess G, et al. P T. 2008 Nov;33(11):652-66. P T. 2008. PMID: 19750061 Free PMC article.

7

IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.

Fillit H, Hess G, Hill J, Bonnet P, Toso C. Fillit H, et al. Among authors: hess g. Neurology. 2009 Jul 21;73(3):180-5. doi: 10.1212/WNL.0b013e3181ae7aaf. Neurology. 2009. PMID: 19620605

8

The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia.

Polsky D, Eremina D, Hess G, Hill J, Hulnick S, Roumm A, Whyte JL, Kallich J. Polsky D, et al. Among authors: hess g. Pharmacoeconomics. 2009;27(9):755-65. doi: 10.2165/11313860-000000000-00000. Pharmacoeconomics. 2009. PMID: 19757869

9

Hemoglobin decline in chemotherapy patients prior to and after policy changes affecting use of erythropoiesis-stimulating agents: 2006-2009.

Hill JW, Cong Z, Hess G, McGarvey N, Nordyke RJ. Hill JW, et al. Among authors: hess g. J Int Med Res. 2012;40(4):1532-45. doi: 10.1177/147323001204000433. J Int Med Res. 2012. PMID: 22971506 Free article.

10

Utilization of darbepoetin alfa in relation to cancer patients' hemoglobin levels.

Hess G, Hill J, Clough J, Hulnick S, Nordyke RJ. Hess G, et al. Curr Med Res Opin. 2008 Mar;24(3):815-9. doi: 10.1185/030079908X280383. Epub 2008 Feb 6. Curr Med Res Opin. 2008. PMID: 18257979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

884 results

Search Page

Filters